Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [915]

Experiences of women caring for their husbands with cancer at the Cancer...

Mrs Patience Mbozi - Chreso University, Lusaka, Zambia

Experiences of women caring for their husbands with cancer at the Cancer Diseases Hospital in Zambia ( Mrs Patience Mbozi - Chreso University, Lusaka, Zambia )

Immunotherapy developments and new agents for locally advanced NSCLC and SCLC

Dr Edgardo Santos - Florida Precision Oncology, Florida, USA

Immunotherapy developments and new agents for locally advanced NSCLC and SCLC ( Dr Edgardo Santos - Florida Precision Oncology, Florida, USA )

Predictive and prognostic biomarkers for immunotherapy in lung cancer

Dr Ignacio Gil Bazo - Fundación Instituto Valenciano de Oncología (FIVO)...

Predictive and prognostic biomarkers for immunotherapy in lung cancer ( Dr Ignacio Gil Bazo - Fundación Instituto Valenciano de Oncología (FIVO), Valencia, Spain )

Immunotherapy in NSCLC: Adjuvant and neoadjuvant clinical scenarios

Dr Luis Raez - Memorial Healthcare System, Florida, USA

Immunotherapy in NSCLC: Adjuvant and neoadjuvant clinical scenarios ( Dr Luis Raez - Memorial Healthcare System, Florida, USA )

ASCO 2023: Lung cancer research highlights

Dr Luis Raez - Memorial Cancer Institute, Miami, USA

ASCO 2023: Lung cancer research highlights ( Dr Luis Raez - Memorial Cancer Institute, Miami, USA )

KEYNOTE-716: Longer follow up supports pembrolizumab use in stage IIB/IIC...

Prof Jason J Luke - University of Pittsburgh, Pittsburgh, USA

KEYNOTE-716: Longer follow up supports pembrolizumab use in stage IIB/IIC melanoma ( Prof Jason J Luke - University of Pittsburgh, Pittsburgh, USA )

Tumour Treating Fields therapy extends OS for mNSCLC after plantinum failure

Dr Ticiana Leal - Emory University, Atlanta, USA

Tumour Treating Fields therapy extends OS for mNSCLC after plantinum failure ( Dr Ticiana Leal - Emory University, Atlanta, USA )

ASCO 2023: Highlights and analysis

Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada

ASCO 2023: Highlights and analysis ( Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada )

Osimertinib after surgery significantly improves survival in resected EGFR...

Prof Roy Herbst - Yale Cancer Center, New Haven, USA

Osimertinib after surgery significantly improves survival in resected EGFR-mutated NSCLC ( Prof Roy Herbst - Yale Cancer Center, New Haven, USA )

Pembrolizumab improves OS in firstline treatment for unresectable advanced...

Dr Penelope Bradbury - Princess Margaret Cancer Centre, Toronto, Canada

Pembrolizumab improves OS in firstline treatment for unresectable advanced pleural mesothelioma ( Dr Penelope Bradbury - Princess Margaret Cancer Centre, Toronto, Canada )

Pembro plus chemo followed by resection and adjuvant pembro improves on...

Prof Heather Wakelee - Stanford Cancer Institute, Stanford, USA

Pembro plus chemo followed by resection and adjuvant pembro improves on standard of care for early NSCLC ( Prof Heather Wakelee - Stanford Cancer Institute, Stanford, USA )

Tackling low-volumes of clinical trials in Africa

Prof Ifeoma Okoye - University of Nigeria, Nsukka, Nigeria

Tackling low-volumes of clinical trials in Africa ( Prof Ifeoma Okoye - University of Nigeria, Nsukka, Nigeria )

More from ecancer